Solid organ transplant recipients during COVID‐19 pandemic

We read with interest the correspondence from Montagud-Marrahi et al. putting forward that solid organ transplant (SOT) recipients are not at higher risk of severe COVID-19 infection despite their immunosuppression and the mild or atypical nature of their symptoms in their Spanish cohort. In the recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill. Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered.